Brellium operates an AI-powered clinical compliance platform that audits 100% of clinical documentation in real time, protecting healthcare providers against documentation errors and compliance violations. Founded in 2021 and headquartered in New York, the company has secured $16.7 million in Series A funding led by First Round Capital, Left Lane Capital, and Menlo Ventures.
The platform integrates directly with existing EMR systems to identify compliance risks before claims are submitted, preventing costly denials and clawbacks. Brellium has protected over $1.4 billion in claims for more than 250,000 providers operating across all 50 U.S. states. Beyond detection, the platform delivers comprehensive dashboards, automated evidence assembly for payor audits, quality trend analytics, and personalized provider training based on identified documentation gaps.
The company serves healthcare providers across behavioral health, ABA therapy, mental health, hospice, and general clinical settings. Its continuous compliance monitoring approach surfaces quality trends while automating the evidence-gathering process during payor audits, reducing administrative burden and financial exposure for healthcare organisations.
